Flathead Valley Parkinson's Support Group

Do you have Parkinson’s Disease and depression? Join Our Clinical Trial.

Yale University is evaluating the safety and effectiveness of an FDA-approved antidepressant called ketamine for individuals with Parkinson’s disease (PD). 

• We believe that ketamine could reduce depression and possibly target other symptoms of PD. 
• Participants will be randomly assigned to receive either the study drug (ketamine) or placebo (doesn’t have an active component) twice a week for 3 weeks.
• You will also have the option to take part in brain imaging before and after the treatment. 
• You will be reimbursed up to $2000 for your time. 

You may be eligible to join the study if you: 

• Are between 40-80 years old 
• Have a diagnosis of PD
• Have symptoms of depression  

Contact us to find out more!

E-mail: ketaminepd@yale.edu Call or Text: (475) 287-9521